文献速递乳腺乳腺X线

商用人工智能乳腺X线计算机辅助诊断异常评分的阳性预测值

Positive Predictive Values of Abnormality Scores From a Commercial Artificial Intelligence-Based Computer-Aided Diagnosis for Mammography.
PubMed 文献 · Korean J Radiol · 2024-01-01

本研究回顾性纳入2020年3月至2022年5月接受乳腺X线检查且AI-CAD异常评分≥10的656侧乳腺(599例女性),分析异常评分与临床及影像学因素的关系。AI-CAD总体阳性预测值为32.5%,筛查亚组为18.6%且随评分分组升高而升高;诊断性检查、可触及肿块、脂肪型乳腺及特定影像学表现者阳性预测值更高。

要点

  • AI-CAD异常评分越高,阳性预测值越高,筛查亚组评分90-100组阳性预测值达96.3%。
  • 筛查乳腺X线AI-CAD总体阳性预测值为18.6%,符合BI-RADS可接受范围。
  • 诊断性乳腺X线阳性预测值(45.1%)高于筛查,可触及肿块者达51.9%。

核心结论

  • AI-CAD阳性预测值随异常评分升高而升高;筛查乳腺X线的阳性预测值符合BI-RADS可接受范围,诊断性乳腺X线者更高。

研究设计与样本

  • 回顾性研究,纳入2020年3月至2022年5月599例女性(平均年龄52.6±11.5岁,含0.6%[4/599]高危女性)的656侧乳腺,均接受乳腺X线检查且AI-CAD(Lunit Insight MMG)异常评分≥10;采用单因素和多因素分析评估评分与临床及影像学因素的关系,用最优分箱法将乳腺按评分分为1组(10-49)、2组(50-69)、3组(70-89)、4组(90-100)。

诊断标准与关键数值

  • AI-CAD总体阳性预测值为32.5%(213/656);筛查乳腺X线亚组总体阳性预测值为18.6%(58/312),评分1、2、3、4组阳性预测值分别为5.1%(12/235)、29.0%(9/31)、57.9%(11/19)、96.3%(26/27);诊断性指征者阳性预测值为45.1%(155/344),可触及肿块者为51.9%(149/287),脂肪型乳腺为61.2%(60/98)。

临床应用与阅片要点

  • 阅读AI-CAD结果时,异常评分越高提示恶性风险越高;筛查乳腺X线评分1组阳性预测值仅5.1%,评分4组达96.3%;诊断性指征、可触及肿块、脂肪型乳腺及肿块伴或不伴钙化、结构扭曲等影像学表现者阳性预测值更高。

局限性

  • 本研究为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Artificial intelligence-based computer-aided diagnosis (AI-CAD) is increasingly used in mammography. While the continuous scores of AI-CAD have been related to malignancy risk, the understanding of how to interpret and apply these scores remains limited. We investigated the positive predictive values (PPVs) of the abnormality scores generated by a deep learning-based commercial AI-CAD system and analyzed them in relation to clinical and radiological findings.

MATERIALS AND METHODS: From March 2020 to May 2022, 656 breasts from 599 women (mean age 52.6 ± 11.5 years, including 0.6% [4/599] high-risk women) who underwent mammography and received positive AI-CAD results (Lunit Insight MMG, abnormality score ≥ 10) were retrospectively included in this study. Univariable and multivariable analyses were performed to evaluate the associations between the AI-CAD abnormality scores and clinical and radiological factors. The breasts were subdivided according to the abnormality scores into groups 1 (10-49), 2 (50-69), 3 (70-89), and 4 (90-100) using the optimal binning method. The PPVs were calculated for all breasts and subgroups.

RESULTS: Diagnostic indications and positive imaging findings by radiologists were associated with higher abnormality scores in the multivariable regression analysis. The overall PPV of AI-CAD was 32.5% (213/656) for all breasts, including 213 breast cancers, 129 breasts with benign biopsy results, and 314 breasts with benign outcomes in the follow-up or diagnostic studies. In the screening mammography subgroup, the PPVs were 18.6% (58/312) overall and 5.1% (12/235), 29.0% (9/31), 57.9% (11/19), and 96.3% (26/27) for score groups 1, 2, 3, and 4, respectively. The PPVs were significantly higher in women with diagnostic indications (45.1% [155/344]), palpability (51.9% [149/287]), fatty breasts (61.2% [60/98]), and certain imaging findings (masses with or without calcifications and distortion).

CONCLUSION: PPV increased with increasing AI-CAD abnormality scores. The PPVs of AI-CAD satisfied the acceptable PPV range according to Breast Imaging-Reporting and Data System for screening mammography and were higher for diagnostic mammography.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee SE, Hong H, Kim EK, et al. Positive Predictive Values of Abnormality Scores From a Commercial Artificial Intelligence-Based Computer-Aided Diagnosis for Mammography. Korean J Radiol. 2024. PMID: 38528692. doi:10.3348/kjr.2023.0907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。